Beasley Allen has one of the largest and most technologically advanced Mass Torts practices in the country. The Mass Torts division represents numerous people in claims against companies that manufacture and/or market defective pharmaceuticals and/or medical devices. The resources devoted to this division allow the firm to competently and conscientiously handle any group of cases, no matter how large, along with particular catastrophic injury cases.
Our firm was recently involved in one of the greatest victories in Mass Torts history, against drug manufacturer Merck regarding the drug Vioxx. After more than five years of hard-fought and difficult litigation, Merck agreed to pay $4.85 billion, the largest pharmaceutical settlement in U.S. history, to resolve certain Vioxx-related claims involving plaintiffs who suffered a heart attack, including sudden cardiac death, or a stroke.
New York City health officials have identified the first suspected woman-to-man sexual transmission of the mosquito-borne Zika virus. The unnamed woman “engaged in a single event of condomless vaginal intercourse with a male partner the day she returned to NYC from travel to an area with ongoing Zika virus transmission,” said Alexander Davidson with the NYC Department of Health and Mental Hygiene. At the time, the woman was showing symptoms of Zika infection. A week later, the man she had intercourse with was also diagnosed with Zika and exhibiting symptoms such as fever, rash, joint pain and conjunctivitis. Researchers determined ... Read More
Dr. Steve Tower specializes in hip, knee and shoulder surgery as well as general orthopedics and trauma care. In 2006, Tower had hip replacement surgery and received a metal-on-metal hip implant design made of chrome cobalt. A year after the hip was replaced, he began experiencing pain. Having replaced “about a thousand” hips in patients himself, Tower knew this was not the norm. Remembering that the hip was made of cobalt, he decided to have his blood levels checked. He found the cobalt levels in his blood to be extremely high. Three years after replacement, the hip became so painful that revision ... Read More
PharmaTech LLC is recalling all unexpired lots of Diocto Liquid, a docusate sodium stool softener distributed by Rugby Laboratories after testing by the Food and Drug Administration (FDA) confirmed the solution was contaminated with Burkholderia cepacia, a bacteria linked to an outbreak of infections in patients in five states. B. cepacia bacteria can cause potentially serious respiratory infections, especially in patients with cystic fibrosis. Docusate sodium is a stool softener that makes bowel movements softer and easier to pass. The solution is used to treat or prevent constipation and to reduce pain or rectal damage caused by hard stools or by ... Read More
More research should be conducted on a newer class of type 2 diabetes drugs to better understand side effects such as diabetic ketoacidosis and bone fractures, and to determine if the risks are drug-specific or spread among all treatments in the class, said Rodica Busui, MD, PhD, with the University of Michigan Health System. Sodium-glucose co-transporter 2 (SGLT2) inhibitors are a new type of type 2 diabetes treatment that lower blood sugar by blocking the reabsorption of glucose in the kidneys and increase the excretion of glucose through the urine. Brand names include Invokana, Invokamet, Farxiga, Xigduo and Jardiance. The first ... Read More
Shaquil Byrd’s childhood was difficult enough, with a mental condition that required antipsychotic medication. At age 10, things got increasingly worse when he grew female breasts. He dealt with constant teasing from his classmates. “I was going to war to protect myself from the things people would say to me,” he said. His mother, Eugenia Jordan, says her son’s tender and lactating breasts robbed him of a normal childhood. “He did a lot of crying. He was very uncomfortable around other people,” she said. When she and Shaquil, now 22, learned that his condition, called gynecomastia, was possibly caused by ... Read More
Nexium, one of the most prescribed drugs in the United States, is a proton pump inhibitor or PPI. Attorneys Mike Papantonio and Neil Overholtz, on a recent program broadcast on Ring of Fire Network, discuss the potential dangers of these drugs (which also include well-known Prilosec and Prevacid). Used to treat heartburn and acid reflux symptoms, they are available both by prescription and over the counter. But according to both men, recent literature published on the subject is saying that only 25 percent of PPI users actually need the medicine. Overutilization of PPIs is troubling not only because the drugs ... Read More
A federal judge in Phoenix has been appointed to oversee an upwards of 400 cases in a multidistrict litigation (MDL) in which patients claim C.R. Bard manufactured a defective product with the retrievable inferior vena cava (IVC) filter. IVC filters are cage-like devices that are implanted in the largest vein of the body. Their purpose is to catch blood clots, preventing them from reaching the heart or lungs, particularly in patients that cannot take anticoagulation medication. Retrievable IVC filters are meant to be temporary, and the FDA recommends retrieval between 29 and 54 days after insertion. Bard’s retrievable filters are the Recovery, G2 and G2 Express. ... Read More
People should be vigilant about telling their doctors about every medicine or vitamin they are taking because the products they are taking may cause or worsen heart failure, the American Heart Association (AHA) advised in a new scientific statement. The average heart failure patient takes an average of seven prescriptions a day. More than a third also take herbal or dietary supplements. “When a patient takes at least four medications the risk for a drug-drug interaction increases to 38 percent; this number increases to 82 percent when patients are taking seven or more medications, which many patients with heart failure ... Read More
The Food and Drug Administration (FDA) has issued a warning letter to a dietary supplement manufacturer Mc-Cor, LLC, because its promotion of “ClucoCoR” capsules makes claims to treat type 1 and 2 diabetes and other conditions, a clear violation of the Federal Food, Drug and Cosmetic Act. The product was sold on the company’s website www.metacorlic.com/en, touting claims such as: “Promote healthy glucose levels” “Promote… tissue repair” “GlucoCor is a Metabolic Corrector” “Helps maintain adequate levels of blood sugar” “Attends the biochemical origin of the disease” “Treatment for Diabetes 1 and 2 diabetes GlucoCor” “Metabolic Correction for Diabetes Type 2 ... Read More
Men who received a large-head metal-on-metal hip implant had nearly double the risk of heart failure than men who received a metal-on-polyethylene, said Stephen Graves, M.D., at the American Academy of Orthopaedic Surgeons Annual Meeting. According to a study led by Dr. Graves, 2,115 men had total hip arthroplasties between January 2003 – December 2012. Of those men, 2,028 received metal-on-polyethylene and 87 received the ASR XL, the DePuy Synthes Joint Reconstruction. The ASR XL recipients had “significant increased risk” of heart failure – one in 10, to be exact. The study strongly suggests that the men who have received the ASR XL should have “close ... Read More